Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer.

ABSTRACT

OBJECTIVE: Non-small-cell lung cancer (NSCLC) accounts for >85% of lung cancers, and its incidence is increasing. We explored expression differences between NSCLC and normal cells and predicted potential target sites for detection and diagnosis of NSCLC. METHODS: Three microarray datasets from the Gene Expression Omnibus database were analyzed using GEO2R. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis were conducted. Then, the String database, Cytoscape, and MCODE plug-in were used to construct a protein-protein interaction (PPI) network and screen hub genes. Overall and disease-free survival of hub genes were analyzed using Kaplan-Meier curves, and the relationship between expression patterns of target genes and tumor grades were analyzed and validated. Gene set enrichment analysis and receiver operating characteristic curves were used to verify enrichment pathways and diagnostic performance of hub genes. RESULTS: In total, 293 differentially expressed genes were identified and mainly enriched in cell cycle, ECM-receptor interaction, and malaria. In the PPI network, 36 hub genes were identified, of which 6 were found to play significant roles in carcinogenesis of NSCLC CDC20, ECT2, KIF20A, MKI67, TPX2, and TYMS. CONCLUSION: The identified target genes can be used as biomarkers for the detection and diagnosis of NSCLC.